Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05641584

Is Monocyte/HDL Ratio a Predictor of Mortality in Aortic Valve Surgery

Conditions: Inflammation, Aortic Valve Stenosis, HDL

Sex: All
Ages: 18 Years – N/A
Enrollment: 1
Sponsor: Bakirkoy Dr. Sadi Konuk Research and Training Hospital

Location: Turkey

Summary

In this study, the investigators aimed to determine whether the preoperative Monocyte/HDL ratio would be a predictor of postoperative mortality and morbidity in patients who underwent aortic valve replacement due to aortic stenosis.

Eligibility Criteria

Inclusion Criteria:be over the age of 18, ASA II-IV Patients scheduled for cardiac surgery due to on-pomp aortic valve replacementExclusion Criteria:emergency operations, off pump)pumpless surgery, revision (repetitive) operations, those with signs of acute infection, those with autoimmune disease, those with severe renal (serum creatinine >2.0 mg/dl) disease, those with severe hepatic disease, those with suspected malignancy, patients where data variables cannot be saved due to technical problems.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05641584). StuddyBuddy aggregates publicly available trial information.